Alector Alternatives & Competitors
12 companies similar to Alector — We are on a mission to make brain disorders history.
Companies similar to Alector
Cantabio Pharmaceuticals, Inc.
Cantabio aim to slow, stop and even prevent the onset & progression of neurodegenerative d...
Vigil Neuroscience
Harnessing the power of microglia to transform treatments for neurodegenerative diseases
Lys Therapeutics
First-in-class biotherapies against neurological diseases. Targeting neuroinflammation t...
Rival Readout
Competing with Alector? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
AFFiRiS AG
Novel disease-modifying therapies for neurodegenerative diseases. From brains for brains....
ZelosDx
We develop blood testing products to help researchers make breakthrough discoveries in bra...
HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
AviadoBio
A revolution in gene therapy for neurodegenerative disorders.
Gain Therapeutics
Unfolding the next generation of allosteric small molecule therapies to meet patient needs...
ESCAPE Bio
A CLINICAL-STAGE COMPANY DEVELOPING NOVEL, PRECISELY TARGETED THERAPIES FOR GENETIC NEUROD...
About Alector
Alector, founded in 2013 and headquartered in the United States, is a cutting-edge player in the Biotechnology sector, focused on transforming approaches to Health Care and Pharmaceuticals. With the bold mission "to make brain disorders history," Alector is anchored in a late-stage clinical phase with a strong portfoli...
Development of therapies for neurodegenerative diseases, Conducting clinical trials, Research in human genetics, neuroscience, and immunology
Patients with neurodegenerative diseases, Healthcare providers, Research institutions
Neurodegenerative Diseases, Clinical Development, Antibody Discovery, Protein Engineering, Blood-Brain Barrier Technology, Alzheimer's Disease, Neuroimmunology, Genetic Targeting, Therapeutic Development, Neuroscience, Innovative Therapies, Drug Development, Lysosomal Dysfunction, Immune System Restoration
B2B, B2B2C, White Label
Product Sales, Licensing, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Alector: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Alector on 16 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.